CollPlant Biotechnologies (CLGN) Receivables (2016 - 2026)
CollPlant Biotechnologies (CLGN) reported Receivables of $16,000 for the quarter ended Jun 30, 2026.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Receivables (2016 - 2026) Analysis & Trends
As of Dec 31, 2025, CollPlant Biotechnologies posted Receivables of $1,000, down 99.3% from the prior year.
- Receivables has a five-year compound annual growth rate of -73.9% (years ended Dec 2020 to Dec 2025).
- By year, Receivables came in at $150,000 in the year ended Dec 31, 2024, $9,000 in the year ended Dec 31, 2022 (-96.7%) and $270,000 in the year ended Dec 31, 2021 (-67.5%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Receivables since the quarter ended Dec 31, 2024.
- The high point for year-over-year Receivables in five years was the quarter ended Sep 30, 2025 (growth of 120.0%); the low point was the quarter ended Dec 31, 2025 (a decline of 99.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | CollPlant Biotechnologies | 4.58 Mn | -17.77 Mn | -456,000.00 | 16,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 323,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Dec 31, 2021 | 270,000.00 |
| Sep 30, 2021 | 135,000.00 |
| Jun 30, 2021 | 277,000.00 |
| Mar 31, 2021 | 174,000.00 |
| Dec 31, 2020 | 830,000.00 |
| Sep 30, 2020 | 891,000.00 |
API Access
CollPlant Biotechnologies Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();